Responsible for directing portfolios of new product developments in two life science business units. • Provide leadership to program managers for laboratory cold storage, temperature control and water analysis products. 7 products launched globally in 2021.• Focus on cross-functional collaboration with development teams in the U.S., Germany, India and Singapore.

Responsible for development of optical coherence tomography (OCT) imaging catheters. • Led programs resulting in successful release of new products:­ - Capsule device for minimally invasive, sedation-less imaging of esophageal tissue, interrogating for pre-cancerous lesions; concept to clinical study in 12 months.­ - Endoscopic imaging probe for bile and pancreatic duct assessment.• Directed investigations for next generation imaging probe platform, biliary line extension, and new cancer detection applications, targeting market growth.

Responsible for leading arthroscopy resection and fluid management development programs.• Program manager for a next generation resection platform development, including electronic controller, ergonomic surgical handpiece, and set of specialty resection blades.• Directed team in redesign of primary market arthroscopy pump, incorporating new hardware and software elements; start to finish in 11 months. • Led programs to develop five premium performance surgical resection blades.

Directed design and development of a minimally invasive implantable heart assist system.• Led the cross-functional team in redesigning the platform for optimal clinical performance; improved pumping efficiency by 40%. • Responsible for driving development of percutaneous heart assist device introducers and sheaths aimed at lower complication rates.

Responsible for development of an optical coherence tomography (OCT) imaging platform.• Built and directed a team of 25 comprising mechanical, electrical, optical, and software engineering professionals.• Led program advancement from inception to a full functionality system in 18 months, completing extensive animal studies.• Responsible for all program aspects including schedule, $10M+ budget, and communications to executive team.

Responsible for all product development activities at this endovascular start-up company.• Successfully led large, complex program to develop a catheter-based therapeutic ultrasound system for vascular occlusions in 20 months.• Expanded technical team by 50% to drive program to timely completion.

Engineering team leader for the development of industry-first fluidjet surgical instruments in orthopedic and spine applications.• Directed three spine surgery device developments from initial concept stage to commercial release, each in 14 months or less.• Led a family of six disposable arthroscopy devices from original concept to product launch.

Technical leader and program manager for a series of best-in-class transesophageal (TEE) and transthoracic ultrasound transducers, from initial concept through to product release and market leadership position.• Spearheaded development of multiple clinical applications including intraoperative and critical care monitoring ultrasound.• Directed a staff of ten engineers in mechanical design, materials science, and acoustic physics disciplines.